PROGEN — Prostatype Genomics AB Balance Sheet
0.000.00%
Last trade - 00:00
- SEK6.09m
- -SEK4.94m
- SEK0.68m
2018 June 30th | 2019 June 30th | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 8.21 | 2.69 | 15.9 | 20.3 | 11.5 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.789 | 0.757 | 0.915 | 0.65 | 2.16 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 9.7 | 4.48 | 17.5 | 21.6 | 14.2 |
Net Property, Plant And Equipment | 0.092 | 0.04 | 0.028 | 0.014 | 0.004 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Total Assets | 19.7 | 17.6 | 33.7 | 40.2 | 31 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3.94 | 2.58 | 4.31 | 3.43 | 4.33 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 13.5 | 9.03 | 5.37 | 4.3 | 4.8 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 6.22 | 8.55 | 28.3 | 35.9 | 26.2 |
Total Liabilities & Shareholders' Equity | 19.7 | 17.6 | 33.7 | 40.2 | 31 |
Total Common Shares Outstanding |